Drug intelligence / Profile preview

Maxwell Tablet

Development stage: Unknown

Overview

Maxwell Tablet is a dietary supplement manufactured by Aceso Pharma, formulated to provide essential nutrients for overall health. It contains Calcium, Vitamin B12, and Vitamin D3. The supplement is designed to support bone health, boost energy levels, and aid in digestion. Its mechanism of action involves the physiological roles of its active ingredients, such as Calcium contributing to bone mineral density, Vitamin B12 acting as a cofactor in cellular metabolism for energy production, and Vitamin D3 activating the Vitamin D receptor to facilitate calcium absorption and bone mineralization.

Brand names: Maxwell Tablet

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Maxwell Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxwell Tablet.

Explore the full profile